IBA signs three new Proteus®ONE contracts with Proton Partners International
IBA signs three new Proteus®ONE contracts with Proton Partners International.
IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed three new contracts with Proton Partners International (PPI), to install three Proteus®ONE* compact proton therapy solutions across the UK. The contracts are subject to financing.
The contracted Proteus®ONE solutions include Pencil Beam Scanning (PBS) and Cone Beam CT (CBCT) capabilities making Proteus®ONE the only compact solution ready for adaptive treatment. The contracts also include a maintenance agreement. The typical end-user price for a Proteus®ONE solution with a maintenance contract is between EUR 35 and 40 million.
Read more here.